These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 14208046)

  • 21. Measles vaccine potency and sero-conversion rates among infants receiving measles immunization in Ilorin, Kwara State, Nigeria.
    Fowotade A; Okonko IO; Nwabuisi C; Bakare RA; Fadeyi A; Adu FD
    J Immunoassay Immunochem; 2015; 36(2):195-209. PubMed ID: 24825255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MEASLES VACCINE TRIALS IN IBADAN.
    HENDRICKSE RG; MONTEFIORE D; SHERMAN PM
    Arch Gesamte Virusforsch; 1965; 16():251-3. PubMed ID: 14322872
    [No Abstract]   [Full Text] [Related]  

  • 23. MEASLES VACCINATION.
    HILLARY IB; MEENAN PN; BEALE AJ
    Lancet; 1965 Aug; 2(7407):317-8. PubMed ID: 14330099
    [No Abstract]   [Full Text] [Related]  

  • 24. INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
    KIMURA M; ISHIGURO Y
    Jpn J Med Sci Biol; 1965 Feb; 18():65-71. PubMed ID: 14300296
    [No Abstract]   [Full Text] [Related]  

  • 25. [IMMUNOLOGIC RESPONSE IN THE COURSE OF A SYSTEMATIC VACCINATION WITH LIVE MEASLES VACCINE IN THE CUSTOMARY AFRICAN ENVIRONMENT].
    BAYLET R; DAUCHY S; REY M; CANTRELLE P
    Bull Soc Med Afr Noire Lang Fr; 1964; 9():209-12. PubMed ID: 14276623
    [No Abstract]   [Full Text] [Related]  

  • 26. EPI sentinel surveillance for Kwara, 1982-1987.
    Babaniyi O
    West Afr J Med; 1993; 12(4):218-22. PubMed ID: 8199064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing epidemiology of measles in Africa.
    Goodson JL; Masresha BG; Wannemuehler K; Uzicanin A; Cochi S
    J Infect Dis; 2011 Jul; 204 Suppl 1():S205-14. PubMed ID: 21666163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FURTHER STUDY OF THE USE OF LIVE ATTENUATED MEASLES-VIRUS VACCINE.
    CHU FT; CHANG IH; SUNG HY; LING CC
    Paediatr Indones; 1964; 149():42-8. PubMed ID: 14279960
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: Need for a heat-stable measles vaccine for use in West and Central Africa.
    Guyer B; McBean AM; Henn AE
    N Engl J Med; 1975 Mar; 292(10):534. PubMed ID: 1117900
    [No Abstract]   [Full Text] [Related]  

  • 30. Measles resurgence following a nationwide measles vaccination campaign in Nigeria, 2005-2008.
    Weldegebriel GG; Gasasira A; Harvey P; Masresha B; Goodson JL; Pate MA; Abanida E; Chevez A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S226-31. PubMed ID: 21666165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PROPHYLACTIC GAMMA GLOBULIN AND LIVE MEASLES VACCINE IN AN ISLAND OF MEASLES.
    BRODY JA; BRIDENBAUGH E
    Lancet; 1964 Oct; 2(7363):811-3. PubMed ID: 14187479
    [No Abstract]   [Full Text] [Related]  

  • 32. COMBINED USE OF HUMAN GAMMA-GLOBULIN AND LIVE MEASLES-VIRUS VACCINE WITH REFERENCE TO SINGLE INOCULATION OF LIVE MEASLES-VIRUS VACCINE IN EARLY INFANCY.
    FUJII R; MINAMITANI M; NAKAMURA K
    Jpn J Med Sci Biol; 1965 Feb; 18():56-64. PubMed ID: 14300295
    [No Abstract]   [Full Text] [Related]  

  • 33. EXPERIENCE IN THE U.S.S.R. IN THE PREVENTION OF MEASLES BY USE OF LIVE VACCINE.
    BOYCHUK LM; SHIKINA ES; MESHALOVA VN; TAROS LY; AMINOVA MG; REVENOK ND; SAFAROV DI
    Ind Med Surg; 1965 Jan; 34():43-50. PubMed ID: 14267212
    [No Abstract]   [Full Text] [Related]  

  • 34. [VACCINATION AGAINST MEASLES WITH LIVE VIRUS FROM THE EDMONSTON STRAIN-NATIONAL EXPERIENCE].
    RISTORI C; BOCCARDO H; MIRANDA M; BORGONO M; STOCKEBRAND S; CANELLO J; MUNOZ S; CARRILLO B; CONCHA F; ASSAEL I; SANCHEZ L; OLIVARI I; ARAVENA M; BURTON S
    Rev Chil Pediatr; 1963 Aug; 34():656-63. PubMed ID: 14089202
    [No Abstract]   [Full Text] [Related]  

  • 35. MEASLES--A SERIOUS PEDIATRIC DISEASE.
    ABRUZZI W
    J Pediatr; 1964 May; 64():750-2. PubMed ID: 14149010
    [No Abstract]   [Full Text] [Related]  

  • 36. Morbidity and mortality patterns among malnourished children in Benin City, Nigeria.
    Ogbeide O; Osuhor PC
    Trop Doct; 1984 Oct; 14(4):178-80. PubMed ID: 6437030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MEASLES VACCINATION. IV. RESPONSES TO TWO DIFFERENT TYPES OF PREPARATIONS GIVEN AS A FOURTH DOSE OF VACCINE.
    NORRBY E; LAGERCRANTZ R; GARD S
    Br Med J; 1965 Mar; 1(5438):813-7. PubMed ID: 14258844
    [No Abstract]   [Full Text] [Related]  

  • 38. [CLINICAL REACTION TO LIVE ATTENUATED ANTIMEASLES VACCINE (EDMONSTON B) IN THE CUSTOMARY SENEGALESE ENVIRONMENT].
    REY M; MAR D; BAYLET R; CANTRELLE P; ANCELLE JP
    Bull Soc Med Afr Noire Lang Fr; 1964; 9():255-67. PubMed ID: 14277980
    [No Abstract]   [Full Text] [Related]  

  • 39. [REPORT OF TEST OF ANTI-MEASLES VACCINATION WITH ATTENUATED LIVING VIRUS].
    CARBONELL JUANICO M; FARRE SOSTRES I; CARDELUS GASSIOT JI; CARBONELL ESTRANY M
    Rev Esp Pediatr; 1963; 19():563-79. PubMed ID: 14094748
    [No Abstract]   [Full Text] [Related]  

  • 40. Measles Virus Infection Among Vaccinated and Unvaccinated Children in Nigeria.
    Faneye AO; Adeniji JA; Olusola BA; Motayo BO; Akintunde GB
    Viral Immunol; 2015; 28(6):304-8. PubMed ID: 26102341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.